TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 25 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $5,000 | -37.5% | 27,870 | 0.0% | 0.00% | – |
| Q2 2016 | $8,000 | +60.0% | 27,870 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | -91.2% | 27,870 | -15.2% | 0.00% | -100.0% |
| Q4 2015 | $57,000 | -50.0% | 32,870 | -46.6% | 0.00% | -50.0% |
| Q3 2015 | $114,000 | -20.8% | 61,514 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $144,000 | -46.5% | 61,514 | 0.0% | 0.00% | -50.0% |
| Q1 2015 | $269,000 | -9.1% | 61,514 | 0.0% | 0.00% | -20.0% |
| Q4 2014 | $296,000 | +6.9% | 61,514 | -7.5% | 0.01% | 0.0% |
| Q3 2014 | $277,000 | -29.3% | 66,514 | 0.0% | 0.01% | -28.6% |
| Q2 2014 | $392,000 | -7.5% | 66,514 | 0.0% | 0.01% | -12.5% |
| Q1 2014 | $424,000 | – | 66,514 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clarus Ventures, LLC | 4,644,705 | $27,357,000 | 9.71% |
| First Washington CORP | 194,440 | $1,145,000 | 0.64% |
| SPHERA FUNDS MANAGEMENT LTD. | 200,000 | $1,178,000 | 0.29% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 286,801 | $1,669,000 | 0.06% |
| EMERALD ADVISERS, LLC | 175,000 | $1,031,000 | 0.06% |
| Pine River Capital Management L.P. | 209,900 | $1,236,000 | 0.02% |
| Alyeska Investment Group, L.P. | 82,943 | $489,000 | 0.01% |
| TFS CAPITAL LLC | 19,147 | $113,000 | 0.01% |
| HighTower Advisors, LLC | 66,514 | $392,000 | 0.01% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 32,143 | $189,000 | 0.01% |